Cargando…

An Expanding World of Novel Psychoactive Substances: Opioids

The abuse of novel psychoactive substances (NPS) has been increasing dramatically worldwide since late 2000s. By the end of 2015, more than 560 NPS had been reported to the European Monitoring Centre for Drugs and Drug Addiction. Although the most popular compounds are synthetic cannabinoids and psy...

Descripción completa

Detalles Bibliográficos
Autor principal:	Zawilska, Jolanta B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492455/ https://www.ncbi.nlm.nih.gov/pubmed/28713291 http://dx.doi.org/10.3389/fpsyt.2017.00110

Ejemplares similares

“Hot” and “Cold” Cognition in Users of Club Drugs/Novel Psychoactive Substances
por: Savulich, George, et al.
Publicado: (2021)

Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
por: Hassan, Zurina, et al.
Publicado: (2017)

Editorial: Old and new psychoactive substances: Pharmacology and potential applications
por: Mayer, Felix P., et al.
Publicado: (2023)

Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2020)

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances
por: Di Trana, Annagiulia, et al.
Publicado: (2020)

Corrigendum: Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2021)

Editorial: Novel Psychoactive Drugs
por: Fattore, Liana, et al.
Publicado: (2019)

Alcohol and psychoactive substance use in a cohort of children followed by child protection in France
por: Essadek, Aziz, et al.
Publicado: (2023)

Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study
por: Więckiewicz, Gniewko, et al.
Publicado: (2023)

Novel Psychoactive Substances in Custodial Settings: A Mixed Method Investigation on the Experiences of People in Prison and Professionals Working With Them
por: Corazza, Ornella, et al.
Publicado: (2020)

AH-7921: the list of new psychoactive opioids is expanded
por: Katselou, Maria, et al.
Publicado: (2015)

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
por: Catalani, Valeria, et al.
Publicado: (2021)

Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports
por: Ordak, Michal, et al.
Publicado: (2021)

Trends in Mortality From Novel Psychoactive Substances as “Legal Highs”: Gender Differences in Manner of Death and Implications for Risk Differences for Women
por: Webb, Lucy, et al.
Publicado: (2022)

Application of Novel Psychoactive Substances: Chemsex and HIV/AIDS Policies Among Men Who Have Sex With Men in Hong Kong
por: Chan, Alex Siu Wing, et al.
Publicado: (2021)

Editorial: New Trends of Substance Abuse: Looking for New Psychotropic Effects of Chem Sex Drugs, Cognitive Enhancers, and New Psychoactive Substances
por: Pichini, Simona, et al.
Publicado: (2020)

Psychotic symptoms and its associated factors relating to psychoactive substance use among the youth population in Northwest Ethiopia
por: Kassew, Tilahun, et al.
Publicado: (2023)

New Psychoactive Substances Consumption in Opioid-Use Disorder Patients
por: Alías-Ferri, Maria, et al.
Publicado: (2022)

Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated
por: Nichols, David E.
Publicado: (2022)

Novel Psychoactive Substances and Behavioral Addictions
por: Martinotti, Giovanni, et al.
Publicado: (2014)

Simultaneous determination of 24 opioids, stimulants and new psychoactive substances in wastewater
por: Bade, Richard, et al.
Publicado: (2019)

Priapism associated with novel psychoactive substance abuse
por: Jones, Patrick, et al.
Publicado: (2015)

Genotoxicity Evaluation of The Novel Psychoactive Substance MTTA
por: Lenzi, Monia, et al.
Publicado: (2023)

Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse
por: Correia, Beatriz, et al.
Publicado: (2022)

Psychoactive substance use, internet use and mental health changes during the COVID-19 lockdown in a French population: A study of gender effect
por: Malandain, Leo, et al.
Publicado: (2022)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

Concentrations of psychoactive substances in blood samples from non‐fatal and fatal opioid overdoses
por: Edvardsen, Hilde Marie Erøy, et al.
Publicado: (2022)

Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016
por: Deen, Adrian A, et al.
Publicado: (2021)

Novel psychoactive substances: What educators need to know
por: Patterson, ZR, et al.
Publicado: (2016)

Sex and Gender Differences in the Effects of Novel Psychoactive Substances
por: Fattore, Liana, et al.
Publicado: (2020)

Simultaneous determination of 137 drugs of abuse, new psychoactive substances, and novel synthetic opioids in meconium by UHPLC-QTOF
por: López-Rabuñal, Ángela, et al.
Publicado: (2021)

Molecular mechanisms of action of stimulant novel psychoactive substances that target the high-affinity transporter for dopamine
por: Sahai, Michelle A., et al.
Publicado: (2021)

ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
por: Engelgardt, Piotr, et al.
Publicado: (2022)

Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
por: Dal Farra, Deborah, et al.
Publicado: (2022)

Substance-Specific and Shared Gray Matter Signatures in Alcohol, Opioid, and Polysubstance Use Disorder
por: Muller, Angela M., et al.
Publicado: (2022)

Editorial: Pharmacology of new psychoactive substances
por: Lutfy, K., et al.
Publicado: (2023)

Novel Psychoactive Substances in Young Adults with and without Psychiatric Comorbidities
por: Martinotti, Giovanni, et al.
Publicado: (2014)

A Neglected Link Between the Psychoactive Effects of Dietary Ingredients and Consciousness-Altering Drugs
por: Smalheiser, Neil R.
Publicado: (2019)

Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon
por: Elsouri, Kawther N, et al.
Publicado: (2022)

Detecting Suicide and Self-Harm Discussions Among Opioid Substance Users on Instagram Using Machine Learning
por: Purushothaman, Vidya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ki9vgc5kuoce7hc0cvjovekgs5